| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC130059658, LOC130059659 +1426 more | Copy number gain | See cases | |
| | LOC130059719, LOC130059720 +1424 more | Copy number gain | See cases | |
| | LOC130059720, LOC130059721 +1041 more | Copy number gain | See cases | |
| | LOC130059461, LOC130059462 +1031 more | Copy number gain | See cases | |
| | LOC130059622, LOC130059623 +832 more | Copy number gain | See cases | |
| | LOC130059744, LOC130059745 +788 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LINC01228, LINC01229 +719 more | Copy number gain | See cases | |
| | LOC101927817, LOC101927863 +691 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | FANCA, LOC112486223 +18 more | Deletion | Fanconi anemia | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Deletion | not provided | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | not provided +1 more | |
| | | Single nucleotide variant | not provided +1 more | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Deletion (5 prime UTR variant) | Malignant Melanoma Susceptibility | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Duplication (5 prime UTR variant) | Malignant Melanoma Susceptibility | |
| | | Deletion (inframe_deletion +1 more) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (synonymous variant) | not specified | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (nonsense) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (synonymous variant) | not specified | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Microsatellite (inframe_deletion) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | not specified | |